• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Pain Management

FDA gives Bexson pre-IND guidance for ketamine formulation delivered by wearable pump

November 18, 2021 By Sean Whooley

Bexson Biomedical Ketamine Pump

Bexson Biomedical announced today that it received pre-investigational new drug guidance from the FDA for its ketamine compound therapy. Santa Barbara, California-based Bexson develops the patented BB106 formulation, a ketamine therapy delivered through a wearable, subcutaneous patch pump in development with Stevanato Group. According to a news release, having reached the milestone of pre-IND guidance, […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Neurological, Pain Management Tagged With: Bexson Biomedical, FDA, Stevanato Group

Drug delivery tech developer Virpax Pharmaceuticals prices $40M offering

September 14, 2021 By Sean Whooley

Virpax

Virpax Pharmaceuticals (NSDQ:VRPX) announced today that it priced an underwritten public offering worth approximately $40 million. Berwyn, Pennsylvania-based Virpax’s offering includes 6.67 million shares of common stock priced at $6 per share, totaling just over $40 million before deducting underwriting discounts and offering expenses. Additionally, the company granted underwriters a 45-day option to purchase up […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Hydrogels, Nanoparticles, Pain Management Tagged With: Virpax Pharmaceuticals

FDA approves Nevro spinal cord stimulation to treat chronic pain with diabetic neuropathy

July 19, 2021 By Sean Whooley

Nevro Senza

Nevro (NYSE:NVRO) announced today that it received FDA approval for its Senza system for treating chronic pain associated with PDN. Redwood City, Calif.-based Nevro’s Senza system’s approval is specific to Nevro’s 10 kHz stimulation, with the company touting that it now has the only spinal cord stimulation system approved by the FDA with a specific indication […]

Filed Under: Diabetes, Featured, Food & Drug Administration (FDA), Neurological, Pain Management, Regulatory/Compliance Tagged With: FDA, Nevro

Fresenius Kabi launches Simplist fentanyl citrate injection

July 6, 2021 By Sean Whooley

Fentanyl citrate simplist fresenius kabi

Fresenius Kabi announced today that it initiated the U.S. introduction of a fentanyl citrate injection in the Simplist pre-filled syringe. Lake Zurich, Ill.-based Fresenius Kabi’s proprietary Simplist ready-to-administer prefilled syringe offers the fentanyl citrate injection at 50 mcg per 1 mL in an effort to reduce waste and diversion while ensuring the safe delivery of […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pain Management Tagged With: freseniuskabi

Medtronic must face pain-pump lawsuit

March 15, 2021 By Nancy Crotti

Medtronic SynchroMed II

A 70-year-old man may proceed with a lawsuit claiming that Medtronic’s SynchroMed II infusion pump is defective and that the company was negligent in manufacturing it. A U.S. District Court judge in West Virginia last week denied Medtronic’s motion to dismiss the lawsuit brought by John David Brumfield, who claims that the pump in the […]

Filed Under: Featured, Legal News, Pain Management Tagged With: Medtronic

PainReform rasies $6M in private placement

March 8, 2021 By Sean Whooley

PainReform

PainReform (NSDQ:PRFX) announced today that it entered into securities purchase agreements to raise approximately $6 million. Herzliya, Israel-based PainReform entered into the agreements with certain institutional investors to raise the $6 million through the private placement of more than 1.3 million ordinary shares and accompanying warrants to purchase up to 652,173 ordinary shares at a […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pain Management, Pharmaceuticals Tagged With: PainReform

Wearable infusion device maker Bexson Biomedical appoints SVP of drug delivery

March 3, 2021 By Sean Whooley

Bexson Biomedical

Bexson Biomedical announced today that it appointed Sheldon Moberg as its new senior vice president of drug delivery. Santa Barbara, Calif.–based Bexson said in a news release that Moberg will lead the development of its drug delivery technologies, starting with a wearable infusion device for its BB106 therapy developed in partnership with Stevanato Group. The […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals Tagged With: Bexson Biomedical, Personnel, Personnel Moves, wearables

Q BioMed wins federal contract for bone cancer drug

March 2, 2021 By Sean Whooley

Q-Biomed

Q BioMed (OTCQB:QBIO) announced today that it signed an agreement for its Strontium89 drug to be included on the Federal Supply Schedule (FSS). New York-based Q BioMed’s agreement with the U.S. government provides U.S. veterans and other federal government agencies and eligible patients access to Strontium89, a treatment for metastatic bone pain related to common […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Oncology, Pain Management, Pharmaceuticals Tagged With: Q BioMed, qbiomed

B. Braun Medical appoints new CFO

February 23, 2021 By Sean Whooley

B. Braun Medical announced today that it appointed James Allen as a senior VP and as the company’s chief financial officer. Allen, a veteran of more than 30 years in finance and management within multiple industries and disciplines, will replace Bruce Heugel, who last year announced that he would retire after more than 20 years at […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pain Management Tagged With: B. Braun Medical, Personnel, Personnel Moves

AmacaThera raises $10.3M in oversubscribed Series A

February 22, 2021 By Sean Whooley

AmacaThera announced today that it completed an oversubscribed $10.3 million Series A financing round. Lumira Ventures led the Series A funding, with existing investors Viva BioInnovator and Sprout BioVentures contributing as well. New investors BDC Capital Women in Technology Venture Fund, Inveready, MBX Capital, CR Capital Management, StandUp Ventures and MaRS IAF participated, too, according […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Hydrogels, Pain Management, Pharmaceuticals, Surgical Tagged With: AmacaThera

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 18
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS